IL6 and rheumatoid arthritis: In RA, proinflammatory cytokines, including tumor necrosis factor- (TNF-) α, interleukin- (IL-) 1, IL-6, and IL-17, disturb the balance between osteoclast and osteoblast activity, often resulting in a net loss of bone.